Concepedia

Publication | Open Access

Evaluation of cAMS for <sup>14</sup> C Microtracer ADME Studies: Opportunities to Change the Current Drug Development Paradigm

DOIFull Paper Access

28

Citations

20

References

2018

Year

Frédéric Lozac’h, Simon Fahrni, Daniele De Maria, Caroline Welte, Joël Bourquin, Hans‐Arno Synal, David Pearson, Markus Walles, Gian Camenisch
Bioanalysis

Abstract

Combustion AMS (cAMS) technology is applicable to microtracer studies. A favorable opinion from EMA to complete the hADME in a Phase I setting was received, opening the possibilities to change drug development.

References

YearCitations

Page 1